An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
Sci Rep
; 11(1): 9023, 2021 04 27.
Article
in En
| MEDLINE
| ID: mdl-33907251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Chloroquine
/
COVID-19 Drug Treatment
/
Hydroxychloroquine
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Sci Rep
Year:
2021
Document type:
Article
Affiliation country:
Brazil